Collaborations & Alliances

Abu Dhabi DoH, AbbVie, M42 Partner on Personalized Medicine

Aims to advance precision medicine in the diagnosis and treatment of multiple myeloma and non-small cell lung cancer in UAE.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Memorandum of Understanding with AbbVie and M42 for collaborative efforts in tailoring personalized medicine and genomics in Abu Dhabi. M42 is a tech-enabled, integrated healthcare company comprised of G42 Healthcare and Mubadala Health.   The three parties aim to advance precision medicine in the diagnosis and treatment of multiple myeloma and non-small cell lung cancer. DoH aims to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters